Cargando…
Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables
In patients with PAH, the ESC/ERS 4-strata risk model maintains some of its discriminative power when one of the three parameters (WHO-FC, 6MWD, and BNP/NT-proBNP) is missing, although with an increasing likelihood of overestimating risk https://bit.ly/46mz83d
Autores principales: | Pausch, Christine, Pittrow, David, Hoeper, Marius M., Huscher, Doerte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695769/ http://dx.doi.org/10.1183/13993003.01023-2023 |
Ejemplares similares
-
Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis
por: Schmidt, Kai-Helge, et al.
Publicado: (2023) -
Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
por: Kramm, Thorsten, et al.
Publicado: (2018) -
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry
por: Hoeper, Marius M., et al.
Publicado: (2022) -
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
por: Hoeper, Marius M., et al.
Publicado: (2015) -
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
por: Hoeper, Marius M., et al.
Publicado: (2022)